O	0	3	Ras	Ras	NN	B-NP
O	3	4	-	-	HYPH	I-NP
O	4	15	association	association	NN	I-NP
O	16	22	domain	domain	NN	I-NP
O	23	29	family	family	NN	I-NP
O	30	32	1C	1C	NN	I-NP
O	33	40	protein	protein	NN	I-NP
O	41	49	promotes	promote	VBZ	B-VP
B-Cell	50	56	breast	breast	NN	B-NP
I-Cell	57	63	cancer	cancer	NN	I-NP
I-Cell	64	68	cell	cell	NN	I-NP
O	69	78	migration	migration	NN	I-NP
O	79	82	and	and	CC	O
O	83	93	attenuates	attenuate	VBZ	B-VP
O	94	103	apoptosis	apoptosis	NN	B-NP
O	103	104	.	.	.	O

O	106	116	BACKGROUND	BACKGROUND	NN	B-NP
O	116	117	:	:	:	O
O	118	121	The	The	DT	B-NP
O	122	125	Ras	Ras	NN	I-NP
O	126	137	association	association	NN	I-NP
O	138	144	domain	domain	NN	I-NP
O	145	151	family	family	NN	I-NP
O	152	153	1	1	CD	I-NP
O	154	155	(	(	(	O
O	155	161	RASSF1	RASSF1	NN	B-NP
O	161	162	)	)	)	O
O	163	167	gene	gene	NN	B-NP
O	168	170	is	be	VBZ	B-VP
O	171	172	a	a	DT	B-NP
O	173	176	Ras	Ras	NN	I-NP
O	177	185	effector	effector	NN	I-NP
O	186	194	encoding	encode	VBG	B-VP
O	195	198	two	two	CD	B-NP
O	199	204	major	major	JJ	I-NP
O	205	209	mRNA	mRNA	NN	I-NP
O	210	215	forms	form	NNS	I-NP
O	215	216	,	,	,	O
O	217	224	RASSF1A	RASSF1A	NN	B-NP
O	225	228	and	and	CC	I-NP
O	229	236	RASSF1C	RASSF1C	NN	I-NP
O	236	237	,	,	,	O
O	238	245	derived	derive	VBN	B-VP
O	246	248	by	by	IN	B-PP
O	249	260	alternative	alternative	JJ	B-NP
O	261	269	promoter	promoter	NN	I-NP
O	270	279	selection	selection	NN	I-NP
O	280	283	and	and	CC	O
O	284	295	alternative	alternative	JJ	B-NP
O	296	300	mRNA	mRNA	NN	I-NP
O	301	309	splicing	splicing	NN	I-NP
O	309	310	.	.	.	O

O	311	318	RASSF1A	RASSF1A	NN	B-NP
O	319	321	is	be	VBZ	B-VP
O	322	323	a	a	DT	B-NP
B-Cancer	324	329	tumor	tumor	NN	I-NP
O	330	340	suppressor	suppressor	NN	I-NP
O	341	345	gene	gene	NN	I-NP
O	345	346	.	.	.	O

O	347	354	However	However	RB	B-ADVP
O	354	355	,	,	,	O
O	356	360	very	very	RB	B-NP
O	361	367	little	little	JJ	I-NP
O	368	370	is	be	VBZ	B-VP
O	371	376	known	know	VBN	I-VP
O	377	382	about	about	IN	B-PP
O	383	386	the	the	DT	B-NP
O	387	395	function	function	NN	I-NP
O	396	398	of	of	IN	B-PP
O	399	406	RASSF1C	RASSF1C	NN	B-NP
O	407	411	both	both	CC	B-PP
O	412	414	in	in	IN	B-PP
O	415	421	normal	normal	JJ	B-NP
O	422	425	and	and	CC	I-NP
O	426	437	transformed	transform	VBN	I-NP
B-Cell	438	443	cells	cell	NNS	I-NP
O	443	444	.	.	.	O

O	445	452	METHODS	METHODS	NNS	B-NP
O	452	453	:	:	:	O
O	454	458	Gene	Gene	NN	B-NP
O	459	468	silencing	silencing	NN	I-NP
O	469	472	and	and	CC	O
O	473	477	over	over	AFX	B-NP
O	477	478	-	-	HYPH	I-NP
O	478	488	expression	expression	NN	I-NP
O	489	499	techniques	technique	NNS	I-NP
O	500	504	were	be	VBD	B-VP
O	505	509	used	use	VBN	I-VP
O	510	512	to	to	TO	B-VP
O	513	521	modulate	modulate	VB	I-VP
O	522	529	RASSF1C	RASSF1C	NN	B-NP
O	530	540	expression	expression	NN	I-NP
O	541	543	in	in	IN	B-PP
O	544	549	human	human	JJ	B-NP
B-Cell	550	556	breast	breast	NN	I-NP
I-Cell	557	563	cancer	cancer	NN	I-NP
I-Cell	564	569	cells	cell	NNS	I-NP
O	569	570	.	.	.	O

O	571	581	Affymetrix	Affymetrix	NN	B-NP
O	581	582	-	-	HYPH	I-NP
O	582	592	microarray	microarray	NN	I-NP
O	593	601	analysis	analysis	NN	I-NP
O	602	605	was	be	VBD	B-VP
O	606	615	performed	perform	VBN	I-VP
O	616	621	using	use	VBG	B-VP
B-Cell	622	626	T47D	T47D	NN	B-NP
I-Cell	627	632	cells	cell	NNS	I-NP
O	633	637	over	over	IN	B-PP
O	637	638	-	-	HYPH	B-NP
O	638	648	expressing	express	VBG	B-VP
O	649	656	RASSF1C	RASSF1C	NN	B-NP
O	657	659	to	to	TO	B-VP
O	660	668	identify	identify	VB	I-VP
O	669	676	RASSF1C	RASSF1C	NN	B-NP
O	677	683	target	target	NN	I-NP
O	684	689	genes	gene	NNS	I-NP
O	689	690	.	.	.	O

O	691	693	RT	RT	NN	B-NP
O	693	694	-	-	HYPH	I-NP
O	694	697	PCR	PCR	NN	I-NP
O	698	701	and	and	CC	O
O	702	709	western	western	JJ	B-NP
O	710	714	blot	blot	NN	I-NP
O	715	725	techniques	technique	NNS	I-NP
O	726	730	were	be	VBD	B-VP
O	731	735	used	use	VBN	I-VP
O	736	738	to	to	TO	B-VP
O	739	747	validate	validate	VB	I-VP
O	748	754	target	target	NN	B-NP
O	755	759	gene	gene	NN	I-NP
O	760	770	expression	expression	NN	I-NP
O	770	771	.	.	.	O

B-Cell	772	776	Cell	Cell	NN	B-NP
O	777	785	invasion	invasion	NN	I-NP
O	786	789	and	and	CC	I-NP
O	790	799	apoptosis	apoptosis	NN	I-NP
O	800	806	assays	assay	NNS	I-NP
O	807	811	were	be	VBD	B-VP
O	812	816	also	also	RB	I-VP
O	817	826	performed	perform	VBN	I-VP
O	826	827	.	.	.	O

O	828	835	RESULTS	RESULTS	NNS	B-NP
O	835	836	:	:	:	O
O	837	839	In	In	IN	B-PP
O	840	844	this	this	DT	B-NP
O	845	852	article	article	NN	I-NP
O	852	853	,	,	,	O
O	854	856	we	we	PRP	B-NP
O	857	863	report	report	VBP	B-VP
O	864	867	the	the	DT	B-NP
O	868	875	effects	effect	NNS	I-NP
O	876	878	of	of	IN	B-PP
O	879	887	altering	alter	VBG	B-VP
O	888	895	RASSF1C	RASSF1C	NN	B-NP
O	896	906	expression	expression	NN	I-NP
O	907	909	in	in	IN	B-PP
O	910	915	human	human	JJ	B-NP
B-Cell	916	922	breast	breast	NN	I-NP
I-Cell	923	929	cancer	cancer	NN	I-NP
I-Cell	930	935	cells	cell	NNS	I-NP
O	935	936	.	.	.	O

O	937	939	We	We	PRP	B-NP
O	940	945	found	find	VBD	B-VP
O	946	950	that	that	IN	B-SBAR
O	951	960	silencing	silence	VBG	B-VP
O	961	968	RASSF1C	RASSF1C	NN	B-NP
O	969	973	mRNA	mRNA	NN	I-NP
O	974	976	in	in	IN	B-PP
B-Cell	977	983	breast	breast	NN	B-NP
I-Cell	984	990	cancer	cancer	NN	I-NP
I-Cell	991	995	cell	cell	NN	I-NP
I-Cell	996	1001	lines	line	NNS	I-NP
O	1002	1003	(	(	(	O
B-Cell	1003	1006	MDA	MDA	NN	B-NP
I-Cell	1006	1007	-	-	HYPH	O
I-Cell	1007	1012	MB231	MB231	NN	B-NP
O	1013	1016	and	and	CC	O
B-Cell	1017	1021	T47D	T47D	NN	B-NP
O	1021	1022	)	)	)	O
O	1023	1029	caused	cause	VBD	B-VP
O	1030	1031	a	a	DT	B-NP
O	1032	1037	small	small	JJ	I-NP
O	1038	1041	but	but	CC	I-NP
O	1042	1053	significant	significant	JJ	I-NP
O	1054	1062	decrease	decrease	NN	I-NP
O	1063	1065	in	in	IN	B-PP
B-Cell	1066	1070	cell	cell	NN	B-NP
O	1071	1084	proliferation	proliferation	NN	I-NP
O	1084	1085	.	.	.	O

O	1086	1096	Conversely	Conversely	RB	B-ADVP
O	1096	1097	,	,	,	O
O	1098	1107	inducible	inducible	JJ	B-ADJP
O	1108	1112	over	over	AFX	O
O	1112	1113	-	-	HYPH	O
O	1113	1123	expression	expression	NN	B-NP
O	1124	1126	of	of	IN	B-PP
O	1127	1134	RASSF1C	RASSF1C	NN	B-NP
O	1135	1137	in	in	IN	B-PP
B-Cell	1138	1144	breast	breast	NN	B-NP
I-Cell	1145	1151	cancer	cancer	NN	I-NP
I-Cell	1152	1157	cells	cell	NNS	I-NP
O	1158	1159	(	(	(	O
B-Cell	1159	1162	MDA	MDA	NN	B-NP
I-Cell	1162	1163	-	-	HYPH	O
I-Cell	1163	1168	MB231	MB231	NN	B-NP
O	1169	1172	and	and	CC	O
B-Cell	1173	1177	T47D	T47D	NN	B-NP
O	1177	1178	)	)	)	O
O	1179	1187	resulted	result	VBD	B-VP
O	1188	1190	in	in	IN	B-PP
O	1191	1192	a	a	DT	B-NP
O	1193	1198	small	small	JJ	I-NP
O	1199	1207	increase	increase	NN	I-NP
O	1208	1210	in	in	IN	B-PP
B-Cell	1211	1215	cell	cell	NN	B-NP
O	1216	1229	proliferation	proliferation	NN	I-NP
O	1229	1230	.	.	.	O

O	1231	1233	We	We	PRP	B-NP
O	1234	1238	also	also	RB	B-ADVP
O	1239	1245	report	report	VBP	B-VP
O	1246	1248	on	on	IN	B-PP
O	1249	1252	the	the	DT	B-NP
O	1253	1267	identification	identification	NN	I-NP
O	1268	1270	of	of	IN	B-PP
O	1271	1276	novel	novel	JJ	B-NP
O	1277	1284	RASSF1C	RASSF1C	NN	I-NP
O	1285	1291	target	target	NN	I-NP
O	1292	1297	genes	gene	NNS	I-NP
O	1297	1298	.	.	.	O

O	1299	1306	RASSF1C	RASSF1C	NN	B-NP
O	1307	1311	down	down	RB	B-ADVP
O	1311	1312	-	-	HYPH	B-NP
O	1312	1321	regulates	regulate	VBZ	B-VP
O	1322	1329	several	several	JJ	B-NP
O	1330	1333	pro	pro	AFX	I-NP
O	1333	1334	-	-	HYPH	I-NP
O	1334	1343	apoptotic	apoptotic	JJ	I-NP
O	1344	1347	and	and	CC	I-NP
B-Cancer	1348	1353	tumor	tumor	NN	I-NP
O	1354	1364	suppressor	suppressor	NN	I-NP
O	1365	1370	genes	gene	NNS	I-NP
O	1371	1374	and	and	CC	O
O	1375	1377	up	up	RB	B-ADVP
O	1377	1378	-	-	HYPH	B-NP
O	1378	1387	regulates	regulate	VBZ	B-VP
O	1388	1395	several	several	JJ	B-NP
O	1396	1402	growth	growth	NN	I-NP
O	1403	1412	promoting	promoting	NN	I-NP
O	1413	1418	genes	gene	NNS	I-NP
O	1419	1421	in	in	IN	B-PP
B-Cell	1422	1428	breast	breast	NN	B-NP
I-Cell	1429	1435	cancer	cancer	NN	I-NP
I-Cell	1436	1441	cells	cell	NNS	I-NP
O	1441	1442	.	.	.	O

O	1443	1445	We	We	PRP	B-NP
O	1446	1453	further	further	RB	B-ADVP
O	1454	1458	show	show	VBP	B-VP
O	1459	1463	that	that	IN	B-SBAR
O	1464	1468	down	down	RB	B-ADVP
O	1468	1469	-	-	HYPH	O
O	1469	1479	regulation	regulation	NN	B-NP
O	1480	1482	of	of	IN	B-PP
O	1483	1490	caspase	caspase	NN	B-NP
O	1491	1492	3	3	CD	I-NP
O	1493	1496	via	via	IN	B-PP
O	1497	1511	overexpression	overexpression	NN	B-NP
O	1512	1514	of	of	IN	B-PP
O	1515	1522	RASSF1C	RASSF1C	NN	B-NP
O	1523	1530	reduces	reduce	VBZ	B-VP
B-Cell	1531	1537	breast	breast	NN	B-NP
I-Cell	1538	1544	cancer	cancer	NN	I-NP
I-Cell	1545	1550	cells	cell	NNS	I-NP
O	1550	1551	'	'	POS	B-NP
O	1552	1563	sensitivity	sensitivity	NN	I-NP
O	1564	1566	to	to	TO	B-PP
O	1567	1570	the	the	DT	B-NP
O	1571	1580	apoptosis	apoptosis	NN	I-NP
O	1581	1589	inducing	induce	VBG	B-VP
O	1590	1595	agent	agent	NN	B-NP
O	1595	1596	,	,	,	O
O	1597	1606	etoposide	etoposide	NN	B-NP
O	1606	1607	.	.	.	O

O	1608	1619	Furthermore	Furthermore	RB	B-ADVP
O	1619	1620	,	,	,	O
O	1621	1623	we	we	PRP	B-NP
O	1624	1629	found	find	VBD	B-VP
O	1630	1634	that	that	IN	B-SBAR
O	1635	1642	RASSF1C	RASSF1C	NN	B-NP
O	1643	1647	over	over	AFX	B-NP
O	1647	1648	-	-	HYPH	I-NP
O	1648	1658	expression	expression	NN	B-NP
O	1659	1667	enhances	enhance	VBZ	B-VP
B-Cell	1668	1672	T47D	T47D	NN	B-NP
I-Cell	1673	1677	cell	cell	NN	I-NP
O	1678	1686	invasion	invasion	NN	I-NP
O	1686	1687	/	/	SYM	B-NP
O	1687	1696	migration	migration	NN	I-NP
O	1697	1699	in	in	FW	B-ADVP
O	1700	1705	vitro	vitro	FW	I-ADVP
O	1705	1706	.	.	.	O

O	1707	1717	CONCLUSION	CONCLUSION	NN	B-NP
O	1717	1718	:	:	:	O
O	1719	1727	Together	Together	RB	B-ADVP
O	1727	1728	,	,	,	O
O	1729	1732	our	our	PRP$	B-NP
O	1733	1741	findings	finding	NNS	I-NP
O	1742	1749	suggest	suggest	VBP	B-VP
O	1750	1754	that	that	IN	B-SBAR
O	1755	1762	RASSF1C	RASSF1C	NN	B-NP
O	1762	1763	,	,	,	O
O	1764	1770	unlike	unlike	IN	B-PP
O	1771	1778	RASSF1A	RASSF1A	NN	B-NP
O	1778	1779	,	,	,	O
O	1780	1782	is	be	VBZ	B-VP
O	1783	1786	not	not	RB	O
O	1787	1788	a	a	DT	B-NP
B-Cancer	1789	1794	tumor	tumor	NN	I-NP
O	1795	1805	suppressor	suppressor	NN	I-NP
O	1805	1806	,	,	,	O
O	1807	1810	but	but	CC	O
O	1811	1818	instead	instead	RB	B-VP
O	1819	1822	may	may	MD	I-VP
O	1823	1827	play	play	VB	I-VP
O	1828	1829	a	a	DT	B-NP
O	1830	1834	role	role	NN	I-NP
O	1835	1837	in	in	IN	B-PP
O	1838	1849	stimulating	stimulate	VBG	B-VP
O	1850	1860	metastasis	metastasis	NN	B-NP
O	1861	1864	and	and	CC	I-NP
O	1865	1873	survival	survival	NN	I-NP
O	1874	1876	in	in	IN	B-PP
B-Cell	1877	1883	breast	breast	NN	B-NP
I-Cell	1884	1890	cancer	cancer	NN	I-NP
I-Cell	1891	1896	cells	cell	NNS	I-NP
O	1896	1897	.	.	.	O

